Showing results 1 to 20 of 43
next >
| Issue Date | Title | Author(s) |
| 2024-03-11 | Evidence for disrupted copper availability in human spinal cord supports CuII(atsm) as a treatment option for sporadic cases of ALS. | Hilton, JBW; Kysenius, K; Liddell, JR; Mercer, SW; Paul, B; Beckman, JS; McLean, CA; White, AR; Donnelly, PS; Bush, AI; Hare, DJ; Roberts, BR; Crouch, PJ |
| 2024-02-05 | Microglial ferroptotic stress causes non-cell autonomous neuronal death. | Liddell, JR; Hilton, JBW; Kysenius, K; Billings, JL; Nikseresht, S; McInnes, LE; Hare, DJ; Paul, B; Mercer, SW; Belaidi, AA; Ayton, S; Roberts, BR; Beckman, JS; McLean, CA; White, AR; Donnelly, PS; Bush, AI; Crouch, PJ |
| 2022-06 | Iron overload and impaired iron handling contribute to the dystrophic pathology in models of Duchenne muscular dystrophy. | Alves, FM; Kysenius, K; Caldow, MK; Hardee, JP; Chung, JD; Trieu, J; Hare, DJ; Crouch, PJ; Ayton, S; Bush, AI; Lynch, GS; Koopman, R |
| 2021-09-29 | Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease. | Finkelstein, DI; Billings, JL; Adlard, PA; Ayton, S; Sedjahtera, A; Masters, CL; Wilkins, S; Shackleford, DM; Charman, SA; Bal, W; Zawisza, IA; Kurowska, E; Gundlach, AL; Ma, S; Bush, AI; Hare, DJ; Doble, PA; Crawford, S; Gautier, ECL; Parsons, J; Huggins, P; Barnham, KJ; Cherny, RA |
| 2021-06-03 | Development of Novel Therapeutics Targeting the Blood–Brain Barrier: From Barrier to Carrier | Li, J; Zheng, M; Shimoni, O; Banks, WA; Bush, AI; Gamble, JR; Shi, B |
| 2021-01-01 | An integrated mass spectrometry imaging and digital pathology workflow for objective detection of colorectal tumours by unique atomic signatures | Paul, B; Kysenius, K; Hilton, JB; Jones, MWM; Hutchinson, RW; Buchanan, DD; Rosty, C; Fryer, F; Bush, AI; Hergt, JM; Woodhead, JD; Bishop, DP; Doble, PA; Hill, MM; Crouch, PJ; Hare, DJ |
| 2020-03 | Regional iron distribution and soluble ferroprotein profiles in the healthy human brain. | McAllum, EJ; Hare, DJ; Volitakis, I; McLean, CA; Bush, AI; Finkelstein, DI; Roberts, BR |
| 2019-07-01 | l-3,4-dihydroxyphenylalanine (l-DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha-synuclein mouse models of Parkinson's disease | Billings, JL; Gordon, SL; Rawling, T; Doble, PA; Bush, AI; Adlard, PA; Finkelstein, DI; Hare, DJ |
| 2019-01-15 | Supranutritional Sodium Selenate Supplementation Delivers Selenium to the Central Nervous System: Results from a Randomized Controlled Pilot Trial in Alzheimer’s Disease | Cardoso, BR; Roberts, BR; Malpas, CB; Vivash, L; Genc, S; Saling, MM; Desmond, P; Steward, C; Hicks, RJ; Callahan, J; Brodtmann, A; Collins, S; Macfarlane, S; Corcoran, NM; Hovens, CM; Velakoulis, D; O’Brien, TJ; Hare, DJ; Bush, AI |
| 2017-07-19 | The APOE ϵ4 Allele Is Associated with Lower Selenium Levels in the Brain: Implications for Alzheimer's Disease | Cardoso, BR; Hare, DJ; Lind, M; McLean, CA; Volitakis, I; Laws, SM; Masters, CL; Bush, AI; Roberts, BR |
| 2017-06-28 | The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease | Finkelstein, DI; Billings, JL; Adlard, PA; Ayton, S; Sedjahtera, A; Masters, CL; Wilkins, S; Shackleford, DM; Charman, SA; Bal, W; Zawisza, IA; Kurowska, E; Gundlach, AL; Ma, S; Bush, AI; Hare, DJ; Doble, PA; Crawford, S; Gautier, EC; Parsons, J; Huggins, P; Barnham, KJ; Cherny, RA |
| 2017-04-28 | The Role of Selenium in Neurodegenerative Diseases | Cardoso, BR; Hare, DJ; Bush, AI |
| 2017-04-01 | Whole-brain metallomic analysis of the common marmoset (: Callithrix jacchus) | Knauer, B; Majka, P; Watkins, KJ; Taylor, AWR; Malamanova, D; Paul, B; Yu, HH; Bush, AI; Hare, DJ; Reser, DH |
| 2017-03-01 | Glutathione peroxidase 4: A new player in neurodegeneration? | Cardoso, BR; Hare, DJ; Bush, AI; Roberts, BR |
| 2017-01-22 | Imaging metals in brain tissue by laser ablation - Inductively coupled plasma - Mass spectrometry (LA-ICP-MS) | Hare, DJ; Kysenius, K; Paul, B; Knauer, B; Hutchinson, RW; O’connor, C; Fryer, F; Hennessey, TP; Bush, AI; Crouch, PJ; Doble, PA |
| 2017-01-01 | Selenium Levels in Serum, Red Blood Cells, and Cerebrospinal Fluid of Alzheimer's Disease Patients: A Report from the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL) | Cardoso, BR; Hare, DJ; Bush, AI; Li, QX; Fowler, CJ; Masters, CL; Martins, RN; Ganio, K; Lothian, A; Mukherjee, S; Kapp, EA; Roberts, BR |
| 2016-11-14 | Rubidium and potassium levels are altered in Alzheimer's disease brain and blood but not in cerebrospinal fluid | Roberts, BR; Doecke, JD; Rembach, A; Yévenes, LF; Fowler, CJ; McLean, CA; Lind, M; Volitakis, I; Masters, CL; Bush, AI; Hare, DJ |
| 2016-11-01 | Delivery of Fluorescent Nanoparticles to the Brain | Shimoni, O; Shi, B; Adlard, PA; Bush, AI |
| 2016-08-15 | Laser ablation-inductively coupled plasma-mass spectrometry imaging of white and gray matter iron distribution in Alzheimer's disease frontal cortex | Hare, DJ; Raven, EP; Roberts, BR; Bogeski, M; Portbury, SD; McLean, CA; Masters, CL; Connor, JR; Bush, AI; Crouch, PJ; Doble, PA |
| 2016-06-01 | Lead and manganese levels in serum and erythrocytes in Alzheimer's disease and mild cognitive impairment: Results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing | Hare, DJ; Faux, NG; Roberts, BR; Volitakis, I; Martins, RN; Bush, AI |
